Atellica VTLi Troponin Testing_Una Health

Una Health announces partnership with Siemens Healthineers

Una Health has announced a new strategic partnership with innovation leader in medtech, Siemens Healthineers for the UK distribution of Atellica® VTLi Patient-side Immunoassay Analyser in primary care.

The point-of-care device delivers proven high-sensitivity troponin I from a small sample of venous whole blood, capillary or plasma. As a recognised worldwide leader in cardiovascular disease testing, Siemens Healthineers High-Sensitivity Troponin I assays provide the clinical sensitivity and precision needed for earlier detection of necrosis and myocardial infarction (MI) versus less-precise assays. Access to accurate results in just 8 minutes helps to streamline chest pain assessment, aiding in earlier disposition decisions for patients not having a MI and fast interventions for those who are.

The CE-marked system is portable, easy to use and aims to transform care delivery for patients, improve ED throughput and aid in optimising the use of time and resources of busy laboratories.

Una Health specialises in innovative point-of-care diagnostics and the optimisation of the patient pathway across all healthcare settings. We look forward to working with Siemens Healthineers to offer fast, accurate and actionable test results to improve the patient journey.